Dilated cardiomyopathy differential diagnosis: Difference between revisions
No edit summary |
|||
Line 33: | Line 33: | ||
* [[ST segment]] changes | * [[ST segment]] changes | ||
* T wave changes | *[[T wave]] changes | ||
* Pathological Q | * Pathological [[Q wave]]<nowiki/>s. | ||
| | | | ||
* Segmental wall motion abnormalities: Location and extent of [[ischemia]]. | |||
* Diagnosis of mechanical complications | |||
* [[ST elevation myocardial infarction risk stratification and prognosis|Risk stratification]] | |||
|- | |- | ||
|Acute [[Pericarditis]] | |Acute [[Pericarditis]] | ||
Line 54: | Line 57: | ||
* Elevated [[C-reactive protein|CRP]] levels. | * Elevated [[C-reactive protein|CRP]] levels. | ||
| | | | ||
* Slight ST segment elevation in several leads | * Slight [[ST segment elevation]] in several leads | ||
* Diffuse T wave inversion | * Diffuse [[T wave inversion]] | ||
| | | | ||
|- | |- |
Revision as of 14:44, 23 December 2019
Dilated cardiomyopathy Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Dilated cardiomyopathy differential diagnosis On the Web |
American Roentgen Ray Society Images of Dilated cardiomyopathy differential diagnosis |
Risk calculators and risk factors for Dilated cardiomyopathy differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdelrahman Ibrahim Abushouk, MD[2]
Overview
Dilated cardiomyopathy should be differentiated from other causes of cardiac dysfunction, in particular acute coronary syndrome, other cardiomyopathies (hypertrophic, restrictive, and ARVC/D), myocarditis, pericarditis, and cardiac toxicities.
Differentiating Dilated Cardiomyopathy from other Diseases
Dilated cardiomyopathy should be differentiated from other causes of cardiac dysfunction, in particular acute coronary syndrome, other cardiomyopathies (hypertrophic, restrictive, and ARVC/D), myocarditis, pericarditis, and cardiac toxicities.[1][2][3][4]
Disorders | Etiology | Clinical Presentation | Laboratory Findings | Electrocardiogram | Echocardiography |
---|---|---|---|---|---|
Acute Coronary Syndrome |
|
|
| ||
Acute Pericarditis |
|
|
|
||
Amphetamine/Cocaine
Cardiomyopathy |
|
|
|
||
Arrhythmogenic right ventricular
cardiomyopathy (ARVC/D) |
|
|
Diagnostic criteria are based on:
|
||
Wet Beriberi |
|
|
|
||
Cardiac Tamponade |
|
|
Echocardiography to score the European Society of Cardiology (ESC) Working Group on Myocardial and Pericardial Diseases | ||
Hyperthyroidism |
|
|
|
||
Hypertrophic Cardiomyopathy |
|
The diagnosis is based on
|
Echocardiography according to ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy | ||
Left ventricular noncompaction |
|
|
Diagnosis can be based on:
|
||
Myocarditis |
|
|
|||
Restrictive Cardiomyopathy | Systemic diseases, such as |
|
|
|
Wall and valvular thickening and sparkling myocardium. |
References
- ↑ Amosova EN (1992). "[Differential diagnosis of dilated cardiomyopathy]". Klin Med (Mosk). 70 (3–4): 14–9. PMID 1507837.
- ↑ Schultheiss HP, Fairweather D, Caforio ALP, Escher F, Hershberger RE, Lipshultz SE; et al. (2019). "Dilated cardiomyopathy". Nat Rev Dis Primers. 5 (1): 32. doi:10.1038/s41572-019-0084-1. PMID 31073128.
- ↑ Gurevich MA, Gordienko BV (2003). "[Dilated and ischemic cardiomyopathy: differential diagnosis]". Klin Med (Mosk). 81 (9): 68–71. PMID 14598597.
- ↑ Gurevich MA, Gordienko BV (2003). "[Dilated and ischemic cardiomyopathy: differential diagnosis]". Klin Med (Mosk). 81 (9): 68–71. PMID 14598597.